Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 55,062,782
- Total 13F value
- $884,310,368
- Share change
- +363,760
- Put/Call ratio
- 0.44%
- SEC-reported price per share
- $16.06
- Number of holders
- 127
- Value change
- +$2,280,401
- Number of buys
- 78
- Number of sells
- 41
- Shares outstanding
- 102,849,349
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
127
Top holders
10
CRNX full security history
Ownership snapshot
Full 13F holder table
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DRIEHAUS CAPITAL MANAGEME...
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
3/4/5
Lead comparable stake: 5.5%
Showing 1-6 of 15 holder rows.
Quick read
DRIEHAUS CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 5.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens DRIEHAUS CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
DRIEHAUS CAPITAL MANAGEMENT LLC
5.5%
PERCEPTIVE ADVISORS LLC
3.9%
BlackRock Finance, Inc.
3.8%
BRAIDWELL LP
3.4%
ORBIMED ADVISORS LLC
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
5.5%
|
$102,932,815
5,624,744 shares
|
— | 31 Dec 2022 |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
10%+ Owner · Company
|
3.9%
from 13F
|
$200,336,855
5,321,032 shares
|
— | 18 Apr 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
3.8%
|
$71,690,049
3,917,489 shares
|
— | 31 Dec 2022 |
| BRAIDWELL LP |
13F
Company
|
3.4%
|
$63,495,034
3,469,674 shares
|
— | 31 Dec 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
3.1%
|
$58,502,831
3,196,876 shares
|
— | 31 Dec 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.7%
|
$51,322,076
2,804,485 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
127
Shares
55,062,782
Rows available
127
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
127
Q1 2023 holders
127
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|